PlainRecalls
FDA Drug Low Class III Terminated

Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.

Reported: October 16, 2013 Initiated: September 25, 2013 #D-66373-001

Product Description

Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.

Reason for Recall

Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.

Details

Recalling Firm
Sandoz Incorporated
Units Affected
25,830 bottles
Distribution
Nationwide
Location
Broomfield, CO

Frequently Asked Questions

What product was recalled?
Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.. Recalled by Sandoz Incorporated. Units affected: 25,830 bottles.
Why was this product recalled?
Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 16, 2013. Severity: Low. Recall number: D-66373-001.